Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Supplemental NDA for Lymphoseek granted priority review by FDA

Feb. 19, 2014

Millennium Pharmaceuticals to conduct PET imaging study of [68Ga]MLN-6907

Feb. 17, 2014

Antibody DNA barcoding used for protein analysis of fine-needle aspirates

Feb. 13, 2014

Novelos Therapeutics changes name

Feb. 12, 2014

Technetium Tc 99m trofolastat accurately detects cancer in the prostate gland

Feb. 11, 2014

Navidea reports initial results from phase IIb trial of its beta-amyloid imaging agent NAV-4694

Feb. 7, 2014

bioTheranostics launches suite of genomic-based tests

Feb. 5, 2014

Radiotracer [18F]VM-4-037 evaluated in phase II renal cancer study

Feb. 3, 2014

Amarantus and Boston University to evaluate test for early signs of neurodegenerative diseases

Jan. 31, 2014

OPS-202 receives EMA orphan drug designation for management of neuroendocrine tumors

Jan. 30, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...